Research & Development



  天太黑,雲瑯的腳下磕絆了一下,努力站穩之後,就看見霍光提著燈籠出現在小路上。   “雲氏醫館,全大漢最好的醫館,幸好把你送到這里來了,如果送到別處,就算你命大能活下來,落下殘疾不可避免。”超碰97人在线视频   他熟讀《馬經》,只要有空閑,就以辨馬,相馬,賽馬為樂,以至于長安賽馬之風頗盛,是唯一能與角斗抗衡的大眾娛樂活動。97色色   雲瑯笑了一下,就把準備好的名單遞給了霍去病跟曹襄,又道︰“這些人都是趙禹懷疑徇私,冒功的人,你們自己最好做一下調查,別回去就把人給弄死,冤枉一兩個不打緊,要是冤枉的範圍大了,就會有麻煩。”   去年的冬天比較暖和,渭水沒有結冰,因此,船老大賺了整整一個冬天的錢,如果今年運氣再好一些,等到秋日還款的時候,就不會有什麼太大的壓力。超碰97资源站   直到金日抱著對面的這個家伙不敢殺死他的絕望想法發起兩敗俱傷的攻擊,他才僥幸活了下來,只是付出的代價也不小。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo